The state of Connecticut is trying a novel approach to reducing its drug spending for the Opioid Dependence drug class of Buprenorphine. Connecticut would like to force all insurance companies, including Medicaid, to purchase Buprenorphine through one manufacturer unless there is a medical reason that it is not possible. Indivior, the maker of a Buprenorphine […]
The state of Connecticut is trying a novel approach to reducing its drug spending for the Opioid Dependence drug class of Buprenorphine. Connecticut would like to force all insurance companies, includ